XML 18 R9.htm IDEA: XBRL DOCUMENT
v3.20.1

Financial Instruments | 3 Months Ended
--- | ---
Feb. 29, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Financing Arrangements and Financial Instruments | FINANCING ARRANGEMENTS AND FINANCIAL INSTRUMENTS During each of the three months ended February 29, 2020 and February 28, 2019, we repaid $18.8 million (representing the required quarterly principal payment) of the five-year term loan due August 17, 2022. We use derivative financial instruments to enhance our ability to manage risk, including foreign currency, net investment and interest rate exposures, which exist as part of our ongoing business operations. We do not enter into contracts for trading purposes, nor are we a party to any leveraged derivative instrument, and all derivatives are designated as hedges. We are not a party to master netting arrangements, and we do not offset the fair value of derivative contracts with the same counterparty in our financial statement disclosures. The use of derivative financial instruments is monitored through regular communication with senior management and the use of written guidelines. Foreign currency exchange risk. We are potentially exposed to foreign currency fluctuations affecting net investments in subsidiaries, transactions (both third-party and intercompany) and earnings denominated in foreign currencies. Management assesses foreign currency risk based on transactional cash flows and translational volatility and may enter into forward contract and currency swaps to reduce fluctuations in the long or short currency positions. Forward contracts are generally less than 18 months duration. Currency swap agreements are established in conjunction with the terms of the underlying debt issues. At February 29, 2020, we had foreign currency exchange contracts to purchase or sell $517.1 million of foreign currencies as compared to $489.2 million at November 30, 2019. All of these contracts were designated as hedges of anticipated purchases denominated in a foreign currency or hedges of foreign currency denominated assets or liabilities. Hedge ineffectiveness was not material. All foreign currency exchange contracts outstanding at February 29, 2020 have durations of less than 12 months, including $194.6 million of notional contracts that have durations of less than seven days and are used to hedge short-term cash flow funding. Contracts which are designated as hedges of anticipated purchases denominated in a foreign currency (generally purchases of raw materials in U.S. dollars by operating units outside the U.S.) are considered cash flow hedges. The gains and losses on these contracts are deferred in accumulated other comprehensive income until the hedged item is recognized in cost of goods sold, at which time the net amount deferred in accumulated other comprehensive income is also recognized in cost of goods sold. Gains and losses from contracts that are designated as hedges of assets, liabilities or firm commitments are recognized through income, offsetting the change in fair value of the hedged item. We also enter into fair value foreign currency exchange contracts to manage exposure to currency fluctuations in certain intercompany loans between subsidiaries. At February 29, 2020, the notional value of these contracts was $400.8 million. During the three months ended February 29, 2020 and February 28, 2019, we recognized (losses) gains of $(2.2) million and $1.7 million, respectively, on the change in fair value of these contracts and gains (losses) of $2.0 million and $(1.8) million, respectively, on the change in the currency component of the underlying loans. Both the gains and the losses were recognized in our consolidated income statement as other income, net. We also utilize cross currency interest rate swap contracts that are considered net investment hedges. As of February 29, 2020, we had cross currency interest rate swap contracts of (i) $250 million notional value to receive $250 million at three-month U.S. LIBOR plus 0.685% and pay £194.1 million at three-month GBP LIBOR plus 0.740% and (ii) £194.1 million notional value to receive £194.1 million at three-month GBP LIBOR plus 0.740% and pay €221.8 million at three-month Euro EURIBOR plus 0.808%. These cross currency interest rate swap contracts expire in August 2027. Interest rate risk. We finance a portion of our operations with both fixed and variable rate debt instruments, principally commercial paper, notes and bank loans. We utilize interest rate swap agreements to minimize worldwide financing costs and to achieve a desired mix of variable and fixed rate debt. As of February 29, 2020, we have outstanding interest rate swap contracts for a notional amount of $350 million. Those interest rate swap contracts include a $100 million notional value of interest rate swap contracts, where we receive interest at 3.25% and pay a variable rate of interest based on three-month LIBOR plus 1.22%, which expire in November 2025, and are designated as fair value hedges of the changes in fair value of $100 million of the $250 million 3.25% medium-term notes due 2025. We also have $250 million notional interest rate swap contracts where we receive interest at 3.40% and pay a variable rate of interest based on three-month LIBOR plus 0.685%, which expire in August 2027, and are designated as fair value hedges of the changes in fair value of $250 million of the $750 million 3.40% term notes due 2027. Any realized gain or loss on these swap contracts was offset by a corresponding increase or decrease of the value of the hedged debt. Hedge ineffectiveness was not material. All derivatives are recognized at fair value in the balance sheet and recorded in either other current assets, other long-term assets, other accrued liabilities or other long-term liabilities, depending upon their nature and maturity. The following table discloses the notional amount and fair values of derivative instruments on our balance sheet (in millions):
As of February 29, 2020 | Asset Derivatives |  |  |  |  |  | Liability Derivatives |  |  |  |
| Balance sheet location |  | Notional amount |  | Fair value |  | Balance sheet location |  | Notional amount |  | Fair value
Interest rate contracts | Other current assets / Other long-term assets |  | $ | 350.0 |  |  | $ | 34.2 |  |  | Other accrued liabilities |  | $ | — |  |  | $ | — |
Foreign exchange contracts | Other current assets |  | 244.1 |  |  | 5.6 |  |  | Other accrued liabilities |  | 273.0 |  |  | 7.6 |
Cross currency contracts | Other current assets / Other long-term assets |  | 247.3 |  |  | 2.6 |  |  | Other long-term liabilities |  | 243.9 |  |  | 1.0 |
Total |  |  |  |  | $ | 42.4 |  |  |  |  |  |  | $ | 8.6 |
As of February 28, 2019 |  | Asset Derivatives |  |  |  |  |  | Liability Derivatives |  |  |  |
| Balance sheet location |  | Notional amount |  | Fair value |  | Balance sheet location |  | Notional amount |  | Fair value
Interest rate contracts | Other current assets / Other long-term assets |  | $ | 250.0 |  |  | $ | 0.1 |  |  | Other accrued liabilities |  | $ | 100.0 |  |  | $ | 4.0 |
Foreign exchange contracts | Other current assets |  | 343.0 |  |  | 3.2 |  |  | Other accrued liabilities |  | 204.8 |  |  | 4.8 |
Cross currency contracts | Other current assets / Other long-term assets |  | — |  |  | — |  |  | Other long-term liabilities |  | 509.8 |  |  | 9.2 |
Total |  |  |  |  | $ | 3.3 |  |  |  |  |  |  | $ | 18.0 |
As of November 30, 2019 | Asset Derivatives |  |  |  |  |  | Liability Derivatives |  |  |  |
| Balance sheet location |  | Notional amount |  | Fair value |  | Balance sheet location |  | Notional amount |  | Fair value
Interest rate contracts | Other current assets / Other long-term assets |  | $ | 350.0 |  |  | $ | 20.9 |  |  | Other accrued liabilities |  | $ | — |  |  | $ | — |
Foreign exchange contracts | Other current assets |  | 293.1 |  |  | 3.3 |  |  | Other accrued liabilities |  | 196.1 |  |  | 3.6 |
Cross currency contracts | Other current assets / Other long-term assets |  | 495.5 |  |  | 3.2 |  |  | Other long-term liabilities |  | — |  |  | — |
Total |  |  |  |  | $ | 27.4 |  |  |  |  |  |  | $ | 3.6 |
The following tables disclose the impact of derivative instruments on our other comprehensive income ("OCI"), accumulated other comprehensive income ("AOCI") and our consolidated income statement for the three-month periods ended February 29, 2020 and February 28, 2019 (in millions):
Fair Value Hedges |  |  |  |  |  |  |  |  |  |
Derivative |  | Income statement location |  | Income (expense) |  |  |  |  |  |
|  |  |  | Three months ended February 29, 2020 |  | Three months ended February 28, 2019 |  |  |  |
Interest rate contracts |  | Interest expense |  | $ | 0.5 |  |  | $ | 0.2 |  |  |  |  |
Three months ended | Income statement location | Gain (loss) recognized in income |  |  | Income statement location | Gain (loss) recognized in income |
Derivative |  | February 29, 2020 | February 28, 2019 | Hedged item |  | February 29, 2020 | February 28, 2019
Foreign exchange contracts | Other income, net | $ | (2.2) |  | $ | 1.7 |  | Intercompany loans | Other income, net | $ | 2.0 |  | $ | (1.8) |
Cash Flow Hedges |  |  |  |  |  |  |  |  |  |
Three months ended |  |  |  |  |  |  |  |  |  |
Derivative |  | Gain or (loss) recognized in OCI |  |  |  | Income statement location |  | Gain or (loss) reclassified from AOCI |  |
|  | February 29, 2020 |  | February 28, 2019 |  |  |  | February 29, 2020 |  | February 28, 2019
Interest rate contracts |  | $ | — |  |  | $ | — |  |  | Interest expense |  | $ | 0.1 |  |  | $ | 0.1 |
Foreign exchange contracts |  | 0.6 |  |  | (1.2) |  |  | Cost of goods sold |  | 0.4 |  |  | 0.3 |
Total |  | $ | 0.6 |  |  | $ | (1.2) |  |  |  |  | $ | 0.5 |  |  | $ | 0.4 |
For all cash flow and settled interest rate fair value hedge derivatives, the net amount of accumulated other comprehensive income (loss) expected to be reclassified in the next 12 months is $0.3 million as an increase to earnings.
Net Investment Hedges |  |  |  |  |  |  |  |  |  |
Three months ended |  |  |  |  |  |  |  |  |  |
Derivative |  | Gain or (loss) recognized in OCI |  |  |  | Income statement location |  | Gain or (loss) excluded from the assessment of hedge effectiveness |  |
|  | February 29, 2020 |  | February 28, 2019 |  |  |  | February 29, 2020 |  | February 28, 2019
Cross currency contracts |  | $ | 0.2 |  |  | $ | (9.5) |  |  | Interest expense |  | $ | 1.3 |  |  | $ | 0.3 |
For all net investment hedges, no amounts have been reclassified out of accumulated other comprehensive income (loss). The amounts noted in the tables above for OCI do not include any adjustments for the impact of deferred income taxes.

X
- Definition The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -URI http://asc.fasb.org/topic&trid=2208564 + Details
Name: | us-gaap_DebtDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration